网站大量收购独家精品文档,联系QQ:2885784924

2006-07年调查-流感疫苗动力,障碍和成本效益 .ppt

2006-07年调查-流感疫苗动力,障碍和成本效益 .ppt

  1. 1、本文档共26页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
2006-07年调查-流感疫苗动力,障碍和成本效益

* * * * * * * * * Talking points The importance of Health Care Workers in motivating Elderly patients and Under 65’s with Chronic Illnesses cannot be understated: The #1 factor that would motivate these patients to get vaccinated – head and shoulders above all others – is a “doctor/nurse recommendation” And if vaccines were reimbursed people would be further motivated to be vaccinated. Conclusion: Health Care Workers, first of all, must remind patients of the importance of being vaccinated But in doing so, they respond to patient questions about influenza vaccine safety and efficacy Notes on the data Notable answers not in overall top 5 for under 65s: UK (44%), Germany (34%), and Ireland (42%) if pharmacist recommended; UK (36%), Germany (41%) and Ireland (32%) if administration other than needle; Germany (52%), Spain (32%), Finland (43%) if could have vaccine at work. Notable outliers for top 5 categories for under 65s: - more info on vaccine efficacy: high Germany (52%) and low (0%) France - more info on vaccine tolerance: high (57%) Germany and low (0%) France - more info disease: high Germany (55%) low France (0%) - cheaper / free: high Germany (46%), Poland (59%) and low Spain (7%) Notable answers not in overall top 5 for over 65s: UK (34%), Germany (40%), Finland (29%) and Ireland (35%) if pharmacist recommended; UK (26%), Germany (43%), Ireland (25%) and Poland (24%) if administration other than needle; Germany (30%) if could have vaccine at work. Notable outliers for top 5 categories for over 65s: - recommendation: low (37%) France - more info on vaccine efficacy: high Germany (45%) and low (0%) France - more info on vaccine tolerance: high (48%) Germany and low (0%) France - more info disease: high Germany (50%) low France (0%) - cheaper / free: high Germany (42%), Poland (48%) and low Spain (2%), Italy (7%) * * * * * * * * * * * * 2 Luxembourg - 14 Feb 08 欧洲11国的季节性流感疫苗 2006年/07年的调查-流感疫苗的推广 动力,障碍和成本效益 Vaccination Strategy Workshop February 14, 2008 -

文档评论(0)

317960162 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档